Rebecca Johnson
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Palliative Care and End-of-Life Issues, Parkinson's Disease Mechanisms and Treatments, Microbial Natural Products and Biosynthesis, Patient-Provider Communication in Healthcare, Grief, Bereavement, and Mental Health
Most-Cited Works
- → Thermal Stability Assessment of Peptide Coupling Reagents Commonly Used in Pharmaceutical Manufacturing(2018)126 cited
- → Evolution of a Highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor(2007)91 cited
- → Interprofessional Models for Shared Decision Making: The Role of the Health Care Chaplain(2018)48 cited
- → Total Synthesis of Pentacyclic (−)-Ambiguine P Using Sequential Indole Functionalizations(2019)46 cited
- → Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors(2021)40 cited
- → Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors(2007)33 cited
- → Oxidative cyclization of prodigiosin by an alkylglycerol monooxygenase-like enzyme(2017)30 cited
- → Alkynylpyrimidine Amide Derivatives as Potent, Selective, and Orally Active Inhibitors of Tie-2 Kinase(2007)29 cited
- → Communicating Chaplains’ Care: Narrative Documentation in a Neuroscience-Spine Intensive Care Unit(2016)25 cited
- → Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership(2015)22 cited